Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01622855 · ClinicalTrials.gov registry record · Phase 1
Acute Intervention to Reduce Distress Following Sexual Assault
A Phase 1 study of Posttraumatic Stress Disorder and Drug Use, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 442
- Enrollment target
- 1
- Study location
NCT01622855 is a Phase 1 study of Posttraumatic Stress Disorder and Drug Use that has completed, run by Medical University of South Carolina. The registered enrollment target is 442 participants, above the 108-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (309% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01622855, a Phase 1 study of Posttraumatic Stress Disorder and Drug Use, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 442 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to evaluate whether a brief intervention in video format delivered in the post assault medical exam setting and including education about assault reactions and instruction in and modeling of successful coping strategies would reduce post assault drug use or abuse and PTSD symptoms as compared to standard care.
Conditions Studied
Interventions
- BEHAVIORAL PPRS
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 1997-03 |
| Est. Completion | 2005-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01622855
The ClinicalTrials.gov registry entry for NCT01622855 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 442 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 108-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (309% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which PPRS is the first listed.
NCT01622855 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT01622855 about?
NCT01622855 is a clinical study titled "Acute Intervention to Reduce Distress Following Sexual Assault". The purpose of this study was to evaluate whether a brief intervention in video format delivered in the post assault medical exam setting and including education about assault reactions and instruction in and modeling of successful coping strategies would reduce post assault drug use or abuse and PT...
What is the current status of trial NCT01622855?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 442 participants. The study started on 1997-03. Estimated completion is 2005-09.
What conditions does trial NCT01622855 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder, Drug Use, Drug Abuse.
What interventions are being tested in trial NCT01622855?
The interventions under investigation include: PPRS (BEHAVIORAL).
Who is sponsoring clinical trial NCT01622855?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01622855 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
RECRUITING · Phase 1
-
Mitigating PTSD-CUD After Sexual Assault
RECRUITING · Phase 1
-
Norepinephrine Transporter Availability in PTSD
COMPLETED · Phase 1
-
Improving Functional Outcomes of Veterans With PTSD and Tobacco Dependence
COMPLETED · Phase 1
-
Stepped Care for Young Children After Trauma
COMPLETED · Phase 1
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.